Compare ALEMBIC with Dishman Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC vs DISHMAN PHARMA - Comparison Results

ALEMBIC     Change

Alembic Limited, in its 99 years of existence, has evolved from being a tincture manufacturer to one of the prominent indigenous pharma companies in India. It is among the top players in the macrolides (anti-infective) and anti-microbials (animal hea... More

DISHMAN PHARMA 
   Change

Dishman Pharmaceuticals is involved in the manufacture of APIs (active pharmaceutical ingredients), intermediates, quaternary compounds and fine chemicals. Besides this, the company is a significant player in the CRAMS (Contract Research and Manufact... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALEMBIC DISHMAN PHARMA ALEMBIC/
DISHMAN PHARMA
 
P/E (TTM) x 57.8 25.1 230.5% View Chart
P/BV x 5.0 3.3 148.9% View Chart
Dividend Yield % 0.2 0.7 30.8%  

Financials

 ALEMBIC   DISHMAN PHARMA
EQUITY SHARE DATA
    ALEMBIC
Mar-18
DISHMAN PHARMA
Mar-16
ALEMBIC/
DISHMAN PHARMA
5-Yr Chart
Click to enlarge
High Rs72374 19.2%   
Low Rs34129 26.3%   
Sales per share (Unadj.) Rs4.7197.8 2.4%  
Earnings per share (Unadj.) Rs6.121.2 28.8%  
Cash flow per share (Unadj.) Rs6.234.7 18.0%  
Dividends per share (Unadj.) Rs0.202.00 10.0%  
Dividend yield (eoy) %0.40.8 47.5%  
Book value per share (Unadj.) Rs40.7179.9 22.6%  
Shares outstanding (eoy) m267.0380.69 330.9%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x11.31.3 885.4%   
Avg P/E ratio x8.711.9 73.1%  
P/CF ratio (eoy) x8.57.2 117.0%  
Price / Book Value ratio x1.31.4 93.1%  
Dividend payout %3.39.4 34.7%   
Avg Mkt Cap Rs m14,13920,306 69.6%   
No. of employees `000NA0.8 0.0%   
Total wages/salary Rs m2075,355 3.9%   
Avg. sales/employee Rs ThNM19,252.7-  
Avg. wages/employee Rs ThNM6,459.5-  
Avg. net profit/employee Rs ThNM2,064.1-  
INCOME DATA
Net Sales Rs m1,25515,961 7.9%  
Other income Rs m370265 139.5%   
Total revenues Rs m1,62516,226 10.0%   
Gross profit Rs m1114,103 2.7%  
Depreciation Rs m381,091 3.5%   
Interest Rs m2944 0.2%   
Profit before tax Rs m4422,334 18.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m1,2121 110,181.8%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m24624 3.8%   
Profit after tax Rs m1,6301,711 95.3%  
Gross profit margin %8.925.7 34.4%  
Effective tax rate %5.426.7 20.3%   
Net profit margin %129.810.7 1,211.2%  
BALANCE SHEET DATA
Current assets Rs m1,86711,018 16.9%   
Current liabilities Rs m5919,517 6.2%   
Net working cap to sales %101.69.4 1,080.9%  
Current ratio x3.21.2 272.8%  
Inventory Days Days94110 85.3%  
Debtors Days Days7435 211.1%  
Net fixed assets Rs m1,79116,304 11.0%   
Share capital Rs m534161 330.9%   
"Free" reserves Rs m10,32412,907 80.0%   
Net worth Rs m10,85814,516 74.8%   
Long term debt Rs m414,189 1.0%   
Total assets Rs m11,59129,805 38.9%  
Interest coverage x260.93.5 7,516.1%   
Debt to equity ratio x00.3 1.3%  
Sales to assets ratio x0.10.5 20.2%   
Return on assets %14.18.9 158.0%  
Return on equity %15.011.8 127.3%  
Return on capital %15.217.5 86.6%  
Exports to sales %1.524.8 6.2%   
Imports to sales %21.03.7 561.5%   
Exports (fob) Rs m193,956 0.5%   
Imports (cif) Rs m263596 44.2%   
Fx inflow Rs m194,952 0.4%   
Fx outflow Rs m264697 37.9%   
Net fx Rs m-2444,255 -5.7%   
CASH FLOW
From Operations Rs m2362,786 8.5%  
From Investments Rs m-224-1,529 14.7%  
From Financial Activity Rs m-27-941 2.8%  
Net Cashflow Rs m-15316 -4.7%  

Share Holding

Indian Promoters % 64.0 61.4 104.2%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.2 3.7 5.4%  
FIIs % 9.7 12.7 76.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 26.1 22.1 118.1%  
Shareholders   54,701 46,261 118.2%  
Pledged promoter(s) holding % 0.0 35.8 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALEMBIC With:   ALKEM LABORATORIES  FRESENIUS KABI ONCO.  FDC  TORRENT PHARMA  STRIDES PHARMA SCIENCE  

Compare ALEMBIC With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Crucial Week Ahead for the Indian Stock Market(Momentum Moves)

The market scaled new life-time highs this week but it was the bears who took control. The benchmark indices, Sensex and Nifty ended mostly flat for the week but the momentum was in favour of the bears.

Related Views on News

ALEMBIC LTD Announces Quarterly Results (1QFY21); Net Profit Up 3.5% (Quarterly Result Update)

Aug 10, 2020 | Updated on Aug 10, 2020

For the quarter ended June 2020, ALEMBIC LTD has posted a net profit of Rs 21 m (up 3.5% YoY). Sales on the other hand came in at Rs 131 m (down 49.7% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

ALEMBIC LTD Announces Quarterly Results (1QFY20); Net Profit Down 70.9% (Quarterly Result Update)

Aug 27, 2019 | Updated on Aug 27, 2019

For the quarter ended June 2019, ALEMBIC LTD has posted a net profit of Rs 20 m (down 70.9% YoY). Sales on the other hand came in at Rs 260 m (down 41.5% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

ALEMBIC LTD Announces Quarterly Results (4QFY19); Net Profit Down 14.6% (Quarterly Result Update)

May 17, 2019 | Updated on May 17, 2019

For the quarter ended March 2019, ALEMBIC LTD has posted a net profit of Rs 40 m (down 14.6% YoY). Sales on the other hand came in at Rs 253 m (down 23.8% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

ALEMBIC LTD Announces Quarterly Results (3QFY19); Net Profit Down 41.9% (Quarterly Result Update)

Feb 1, 2019 | Updated on Feb 1, 2019

For the quarter ended December 2018, ALEMBIC LTD has posted a net profit of Rs 32 m (down 41.9% YoY). Sales on the other hand came in at Rs 243 m (down 18.8% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

ALEMBIC LTD Announces Quarterly Results (1QFY20); Net Profit Down 70.9% (Quarterly Result Update)

Aug 27, 2019 | Updated on Aug 27, 2019

For the quarter ended June 2019, ALEMBIC LTD has posted a net profit of Rs 20 m (down 70.9% YoY). Sales on the other hand came in at Rs 260 m (down 41.5% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

More Views on News

Most Popular

Why Gold Hit Lower Circuit(Fast Profits Daily)

Jan 11, 2021

Were you shocked that bullion prices hit lower circuits on Friday on the MCX? Find out why it happened...

Time to Book Profits in Pharma Stocks(Fast Profits Daily)

Jan 15, 2021

In this video, I'll show you why it might be the right time to take money of the table in pharma stocks.

A Rare Chance to Invest in Potential Multibaggers in 2021(Profit Hunter)

Jan 11, 2021

Our ace stock picker is ready to capitalise on a big growth opportunity.

Smallcap Stocks: Your Best Bet for 2021 and Beyond(Profit Hunter)

Jan 15, 2021

The pandemic failed to thwart Richa's investing success formula for 2020.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC SHARE PRICE


Jan 22, 2021 (Close)

TRACK ALEMBIC

  • Track your investment in ALEMBIC with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE ALEMBIC WITH

MARKET STATS